Cargando…
Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma
Autores principales: | Wang, Qin, Zhou, Jun, Zhong, Dewu, Wang, Qunwei, Huang, Jiangsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374183/ https://www.ncbi.nlm.nih.gov/pubmed/25890348 http://dx.doi.org/10.1186/s40001-015-0132-6 |
Ejemplares similares
-
Ferroportin in the progression and prognosis of hepatocellular carcinoma
por: Wang, Qin, et al.
Publicado: (2013) -
Retraction Note: Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression
por: Wang, Yitao, et al.
Publicado: (2019) -
Retraction Note: Gene expression profiling analysis of hepatocellular carcinoma
por: Kong, Deyong, et al.
Publicado: (2015) -
Retraction Note: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma
por: Lei, Xiong, et al.
Publicado: (2018) -
Retraction Note: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
por: Li, Huifen, et al.
Publicado: (2018)